Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma

Clinical Genitourinary Cancer - Tập 18 - Trang 304-313 - 2020
Alvin Lee1, Han Jie Lee1, Hong Hong Huang1, Kae Jack Tay1, Lui Shiong Lee2, Soon Phang Allen Sim1, Sun Sien Henry Ho1, Shyi Peng John Yuen1, Kenneth Chen1
1Department of Urology, Singapore General Hospital, Singapore
2Department of Urology, Sengkang General Hospital, Singapore

Tài liệu tham khảo

Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 Templeton, 2014, Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis, J Natl Cancer Inst, 106, dju124, 10.1093/jnci/dju124 Takeuchi, 2017, Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer, PLoS One, 12, e0177137, 10.1371/journal.pone.0177137 Hu, 2017, Prognostic value of RDW in cancers: a systematic review and meta-analysis, Oncotarget, 8, 16027, 10.18632/oncotarget.13784 Hu, 2015, Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis, BMJ Open, 5, e006404, 10.1136/bmjopen-2014-006404 De Martino, 2013, Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma, J Urol, 190, 1999 Hutterer, 2014, Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma, Urol Oncol, 32, 1041, 10.1016/j.urolonc.2014.04.001 Leibovich, 2003, Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials, Cancer, 97, 1663, 10.1002/cncr.11234 Zisman, 2002, Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma, J Clin Oncol, 20, 4559, 10.1200/JCO.2002.05.111 Chen, 2019, Evolving trends in the surgical management of renal masses over the past two decades: a contemporary picture from a large prospectively-maintained database, Int J Urol, 26, 465, 10.1111/iju.13909 2002 Camp, 2004, a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization, Clin Cancer Res, 10, 7252, 10.1158/1078-0432.CCR-04-0713 Yoshida, 2002, Interleukin-6, tumour necrosis factor α and interleukin-1b in patients with renal cell carcinoma, Br J Cancer, 86, 1396, 10.1038/sj.bjc.6600257 Sparmann, 2004, Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis, Cancer Cell, 6, 447, 10.1016/j.ccr.2004.09.028 Ohno, 2010, Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma, J Urol, 184, 873 Semeniuk-Wojtaś, 2018, Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and C-reactive protein as new and simple prognostic factors in patients with metastatic renal cell cancer treated with tyrosine kinase inhibitors: a systemic review and meta-analysis, Clin Genitourin Cancer, 16, e685, 10.1016/j.clgc.2018.01.010 Kim, 2019, Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma, Invest Clin Urol, 60, 14, 10.4111/icu.2019.60.1.14 Wang, 2018, Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma, Clin Chim Acta, 480, 166, 10.1016/j.cca.2018.02.014 Życzkowski, 2018, The relationship between red cell distribution width and cancer-specific survival in patients with renal cell carcinoma treated with partial and radical nephrectomy, Clin Genitourin Cancer, 16, e677, 10.1016/j.clgc.2017.12.003 Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 Goubran, 2013, The platelet-cancer loop, Eur J Intern Med, 24, 393, 10.1016/j.ejim.2013.01.017 Palumbo, 2007, Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms, Blood, 110, 133, 10.1182/blood-2007-01-065995 Battinelli, 2011, Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis, Blood, 118, 1359, 10.1182/blood-2011-02-334524 De Vivar Chevez, 2014, The role of inflammation in kidney cancer, Adv Exp Med Biol, 816, 197, 10.1007/978-3-0348-0837-8_9 Mantovani, 2006, Role of tumor-associated macrophages in tumor progression and invasion, Cancer Metastasis Rev, 25, 315, 10.1007/s10555-006-9001-7 Förhécz, 2009, Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state, Am Heart J, 158, 659, 10.1016/j.ahj.2009.07.024 Lippi, 2009, Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients, Arch Pathol Lab Med, 133, 628 Montagnana, 2016, Red cell distribution width and cancer, Ann Transl Med, 4, 399, 10.21037/atm.2016.10.50 Wang, 2017, The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis, Oncotarget, 8, 84506, 10.18632/oncotarget.21108